<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Innovate Corp. — News on 6ix</title>
    <link>https://6ix.com/company/innovate-corp</link>
    <description>Latest news and press releases for Innovate Corp. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 27 Apr 2026 20:21:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/innovate-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835d15078dffbe2df11fa79.webp</url>
      <title>Innovate Corp.</title>
      <link>https://6ix.com/company/innovate-corp</link>
    </image>
    <item>
      <title>INNOVATE Corp. to Report First Quarter 2026 Results on May 14th</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-to-report-first-quarter-2026-results-on-may-14th</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-to-report-first-quarter-2026-results-on-may-14th</guid>
      <pubDate>Mon, 27 Apr 2026 20:21:00 GMT</pubDate>
      <description>NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2026 on Thursday, May 14, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be bro</description>
    </item>
    <item>
      <title>DBM Global to Pay Cash Dividend</title>
      <link>https://6ix.com/company/innovate-corp/news/dbm-global-to-pay-cash-dividend-1</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/dbm-global-to-pay-cash-dividend-1</guid>
      <pubDate>Fri, 03 Apr 2026 18:33:00 GMT</pubDate>
      <description>PHOENIX, April 03, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend of approximately $3 million, or $0.78 per share, on April 28, 2026 to DBMG’s stockholders of record at the close of business on April 13, 2026. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients t</description>
    </item>
    <item>
      <title>MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation</title>
      <link>https://6ix.com/company/innovate-corp/news/medibeaconr-transdermal-gfr-monitor-and-reusable-sensor-receive-ce-mark-under-european-medical-device-regulation</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/medibeaconr-transdermal-gfr-monitor-and-reusable-sensor-receive-ce-mark-under-european-medical-device-regulation</guid>
      <pubDate>Tue, 31 Mar 2026 12:05:00 GMT</pubDate>
      <description>NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced receipt of European Union (EU) CE Mark certification under the EU Medical Device Regulation (MDR) for its TGFR™ Monitor and TGFR™ Reusable Sensor. The certification c</description>
    </item>
    <item>
      <title>INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-announces-fourth-quarter-and-full-year-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-announces-fourth-quarter-and-full-year-2025-results</guid>
      <pubDate>Thu, 26 Mar 2026 20:05:00 GMT</pubDate>
      <description>- Infrastructure: NYC and Western markets continue to demonstrate positive project momentum -- Life Sciences: R2 Secures 600‑System Commitment in China -- Spectrum: Recent network launches set to deliver benefits beginning in 2026 - NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the fourth quarter and full year ended December 31, 2025. Financial Summary (in millions, except per share amounts)Thre</description>
    </item>
    <item>
      <title>INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-to-report-fourth-quarter-and-full-year-2025-results-on-march-26th</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-to-report-fourth-quarter-and-full-year-2025-results-on-march-26th</guid>
      <pubDate>Mon, 16 Mar 2026 20:05:00 GMT</pubDate>
      <description>NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2025 on Thursday, March 26, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call</description>
    </item>
    <item>
      <title>Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)</title>
      <link>https://6ix.com/company/innovate-corp/news/transdermal-gfr-article-recognized-one-210500570</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/transdermal-gfr-article-recognized-one-210500570</guid>
      <pubDate>Tue, 10 Feb 2026 21:05:00 GMT</pubDate>
      <description>MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January 2026 NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE o</description>
    </item>
    <item>
      <title>INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-portfolio-company-dbm-global-133000632</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-portfolio-company-dbm-global-133000632</guid>
      <pubDate>Mon, 02 Feb 2026 13:30:00 GMT</pubDate>
      <description>NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG’s stockholders of record at the close of business on February 9, 2026. As the largest stockholder of DBMG, INNOVATE expects to re</description>
    </item>
    <item>
      <title>MediBeacon® Next Generation TGFR™ System Receives FDA Approval</title>
      <link>https://6ix.com/company/innovate-corp/news/medibeaconr-next-generation-tgfrtm-system-receives-fda-approval</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/medibeaconr-next-generation-tgfrtm-system-receives-fda-approval</guid>
      <pubDate>Tue, 16 Dec 2025 13:05:00 GMT</pubDate>
      <description>MediBeacon® TGFRTM System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers begins in early 2026 NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7</description>
    </item>
    <item>
      <title>INNOVATE Corp. Announces Third Quarter 2025 Results</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-announces-third-quarter-210400013</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-announces-third-quarter-210400013</guid>
      <pubDate>Wed, 12 Nov 2025 21:04:00 GMT</pubDate>
      <description>- Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China -- Spectrum: New network launches underway; Fourth quarter advertising sales showing early signs of recovery - NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the third quarter. Financial Summary (in millions</description>
    </item>
    <item>
      <title>INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-report-third-quarter-200500392</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-report-third-quarter-200500392</guid>
      <pubDate>Wed, 22 Oct 2025 20:05:00 GMT</pubDate>
      <description>NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 12, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also b</description>
    </item>
    <item>
      <title>MediBeacon receives regulatory approval to sell the Transdermal GFR System in China</title>
      <link>https://6ix.com/company/innovate-corp/news/medibeacon-receives-regulatory-approval-to-sell-the-transdermal-gfr-system-in-china</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/medibeacon-receives-regulatory-approval-to-sell-the-transdermal-gfr-system-in-china</guid>
      <pubDate>Tue, 21 Oct 2025 12:05:00 GMT</pubDate>
      <description>MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe TGFR will be available for sale in China before the end of the year NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection</description>
    </item>
    <item>
      <title>INNOVATE Corp. Announces Second Quarter 2025 Results</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-announces-second-quarter-200500204</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-announces-second-quarter-200500204</guid>
      <pubDate>Tue, 05 Aug 2025 20:05:00 GMT</pubDate>
      <description>- Infrastructure: Improved financial flexibility with recent refinancing transactions -- Life Sciences: R2 continuing to see significant year over year growth in system unit sales -- Spectrum: Launched fourth ATSC 3.0 station in collaboration with large mobile carrier - NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the second quarter. Financial Summary (in millions, except per share amounts)Three</description>
    </item>
    <item>
      <title>INNOVATE Closes Indebtedness Refinancing Transactions</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-closes-indebtedness-refinancing-transactions-203000664</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-closes-indebtedness-refinancing-transactions-203000664</guid>
      <pubDate>Mon, 04 Aug 2025 20:30:00 GMT</pubDate>
      <description>INNOVATE’s Maturity Profile Has Been Successfully ExtendedNEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend existing instruments representing 81.7% of the total outstanding principal amount of the Company’s debt as of June 30, 2025 for instruments with longer maturities. The refinancing trans</description>
    </item>
    <item>
      <title>INNOVATE Announces Early Results of Exchange Offer of Senior Secured Notes and Solicitation of Consents and Extends Availability of Total Early Exchange Consideration</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-announces-early-results-exchange-123000133</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-announces-early-results-exchange-123000133</guid>
      <pubDate>Thu, 31 Jul 2025 12:30:00 GMT</pubDate>
      <description>NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced the early participation results as of 5:00 p.m., New York City time, on July 30, 2025 (the “Early Participation Deadline”) of its previously announced exchange offer and consent solicitation (the “Exchange Offer”) to eligible holders of its 8.5% Senior Secured Notes due 2026 (the “Existing Senior Secured Notes”) to exchange such Existing Senior Secured Notes for newly issued 10.5</description>
    </item>
    <item>
      <title>INNOVATE Corp. to Report Second Quarter 2025 Results on August 5th</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-report-second-quarter-200500428</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-report-second-quarter-200500428</guid>
      <pubDate>Thu, 17 Jul 2025 20:05:00 GMT</pubDate>
      <description>NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2025 on Tuesday, August 5, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be br</description>
    </item>
    <item>
      <title>INNOVATE Launches Indebtedness Refinancing Transactions</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-launches-indebtedness-refinancing-transactions-124200788</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-launches-indebtedness-refinancing-transactions-124200788</guid>
      <pubDate>Thu, 17 Jul 2025 12:42:00 GMT</pubDate>
      <description>$48.7 million privately negotiated convertible notes exchanges.$330 million exchange offer of senior secured notes and solicitation of consentsAgreement in principle to extend revolving credit agreementAgreement in principle to amend and extend the CGIC noteAgreement in principle to extend Spectrum notesAgreement in principle to amend and extend the R2 Technologies note NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that it i</description>
    </item>
    <item>
      <title>DBM Global Enters Into an Amended and Restated Credit Agreement</title>
      <link>https://6ix.com/company/innovate-corp/news/dbm-global-enters-into-an-amended-and-restated-credit-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/dbm-global-enters-into-an-amended-and-restated-credit-agreement</guid>
      <pubDate>Tue, 20 May 2025 20:06:00 GMT</pubDate>
      <description>NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), has entered into an amended and restated credit agreement that provides for an $85 million term loan and a $135 million revolving credit facility (the “Credit Facility”), which will be used to fully repay DBMG’s existing debt obligations and provide additional working capital capacity. The Credit Facility from a syndicate led by UMB Bank, N.A. provid</description>
    </item>
    <item>
      <title>INNOVATE Corp. Announces First Quarter 2025 Results</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-announces-first-quarter-200500502</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-announces-first-quarter-200500502</guid>
      <pubDate>Tue, 06 May 2025 20:05:00 GMT</pubDate>
      <description>- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share a</description>
    </item>
    <item>
      <title>INNOVATE Corp. to Report First Quarter 2025 Results on May 6th</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-report-first-quarter-200500529</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-report-first-quarter-200500529</guid>
      <pubDate>Wed, 16 Apr 2025 20:05:00 GMT</pubDate>
      <description>NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broad</description>
    </item>
    <item>
      <title>INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results</title>
      <link>https://6ix.com/company/innovate-corp/news/innovate-corp-announces-fourth-quarter-200400858</link>
      <guid isPermaLink="true">https://6ix.com/company/innovate-corp/news/innovate-corp-announces-fourth-quarter-200400858</guid>
      <pubDate>Mon, 31 Mar 2025 20:04:00 GMT</pubDate>
      <description>- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the fourth quarter. Financial Summary (in millions, except per sha</description>
    </item>
  </channel>
</rss>